Patent Assignment
Reel/Frame 052914/0832
Security Interest
Recorded: 2020-03-20
Pages: 19
Assignor
ALKERMES PHARMA IRELAND LIMITED
Executed: 2020-03-17
Assignee
MORGAN STANLEY SENIOR FUNDING, INC.
1585 BROADWAY, NEW YORK, NEW YORK, 10036
Covered Properties
(56)
Process for the Synthesis of Substituted Morphinans
Aripiprazole Prodrug Compositions
Crystallization Process of Aripiprazole Derivatives in Extended Release Formulations for Treatment of Schizophrenia
Pharmaceutical Compositions Having Improved Storage Stability
COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONIST
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Prodrugs of NH-Acidic Compounds
COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONIST1
Methods for Treating Antipsychotic-Induced Weight Gain
Aripiprazole Formulations Having Increased Injection Speeds
Sulfonamide and Sulfinamide Prodrugs of Fumarates and Their Use in Treating Various Diseases
Pharmaceutical Compositions Comprising Sorbitan Esters
Methods for Treating Depressive Symptoms
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Pharmaceutical Compositions Having Improved Storage Stability
COMPOSITIONS OF BUPRENORPHINE AND µ ANTAGONIST
Compositions of Buprenorphine and µ AntagonistN
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Polymorphic Forms of Naltrexone
Sustained Release Aminopyridine Composition
Application:
15/801,409 →
Publication:
US 2018/0055774
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Methods for Treating Antipsychotic-Induced Weight Gain
Polymorphic Forms of Naltrexone
Process for the Synthesis of Substituted Morphinans
Polymer-Based Sustained Release Device
Application:
15/991,646 →
Publication:
US 2019/0125878
Prodrugs of Nh-Acidic Compounds
Aripiprazole Prodrug Composition
Crystallization Process of Aripiprazole Derivatives in Extended Release Formulations for Treatment of Schizophrenia
Aripiprazole Formulations Having Increased Injection Speeds
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Monomethylfumarate Prodrug Compositions
Application:
16/163,695 →
Publication:
US 2019/0247315
Polymorphic Forms of Naltrexone
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Application:
16/221,884 →
Publication:
US 2019/0382413
Pharmaceutical Compositions Comprising Sorbitan Esters
Application:
16/248,259 →
Publication:
US 2019/0216805
Aripiprazole Formulations Having Increased Injection Speeds
Methods for Treating Depressive Symptoms
Sustained Release Aminopyridine Composition
Application:
16/287,575 →
Publication:
US 2019/0231763
Aripiprazole Dosing Strategy
Methods for Treating Antipsychotic-Induced Weight Gain
Compositions of Buprenorphine and µ AntagonistS
Aripiprazole Prodrug Composition
Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
Pharmaceutical Compositions Having Improved Storage Stability
Prodrugs of Fumarates and Their Use in Treating Various Diseases
Prodrugs of Nh-Acidic Compounds
Crystallization Process of Aripiprazole Derivatives in Extended Release Formulations for Treatment of Schizophrenia
Naltrexone Long Acting Formulations and Methods of Use
Application:
16/656,022 →
Morphinan Derivatives with High Oral Bioavailability
Application:
16/739,262 →
Publication:
US 2020/0383970
Polymer-Based Sustained Release Device
Application:
16/749,584 →
Publication:
US 2020/0390891
Morphinan Derivatives for the Treatment of Drug Overdose
Application:
16/784,574 →
Publication:
US 2020/0345718
Immunomodulatory Il-2 Agents in Combination with Immune Checkpoint Inhibitors
Application:
62/916,936 →
Compositions and Methods for Subcutaneous Administration of Cancer Immunotherapy
Application:
62/924,356 →
Compositions and Methods for Cancer Immunotherapy
Application:
62/932,160 →
Methods of Purification
Application:
62/965,578 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 14, 2015
From: PERRY, JASON M.; DEAVER, DANIEL R.; HICKEY, MAGALI B.; REMENAR, JULIUS F.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 036790/0263 →
Assignment of Assignor's Interest
Feb 2, 2016
From: CRESSWELL, PHILIP; PAQUETTE, SARA MONTMINY; HICKEY, MAGALI; PERKIN, KRISTOPHER
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 037643/0833 →
Security Interest
May 17, 2016
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 038622/0248 →
Assignment of Assignor's Interest
May 26, 2016
From: MORALES, WILFREDO, JR.; ZEIDAN, TAREK A.; CHIARELLA, RENATO A.; WRIGHT, STEVEN G.
To: ALKERMES, INC.
Reel/Frame 038728/0338 →
Assignment of Assignor's Interest
Nov 30, 2016
From: HICKEY, MAGALI B.; VANDIVER, JENNIFER
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 040460/0343 →
Security Interest
Dec 19, 2016
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 040672/0937 →
Assignment of Assignor's Interest
Mar 1, 2017
From: PERRY, JASON M.; DEAVER, DANIEL R.; HICKEY, MAGALI B.; REMENAR, JULIUS F.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 041839/0819 →
Security Interest
Apr 4, 2017
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 041846/0029 →
Corrective Assignment to Correct the Incorrect Serial Number 15/388544 Previously Recorded on Reel 041839 Frame 0819. Assignor(S) Hereby Confirms the Assignment.
Apr 14, 2017
From: PERRY, JASON M.; DEAVER, DANIEL R.; HICKEY, MAGALI B.; REMENAR, JULIUS F.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 042253/0654 →
Assignment of Assignor's Interest
Apr 28, 2017
From: BLUMBERG, LAURA COOK; DEAVER, DANIEL R. R.; EYERMAN, DAVID J.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 042174/0040 →
Corrective Assignment to Correct the Spelling of the Second Assignor Daniel R. Deaver Previously Recorded on Reel 042174 Frame 0040. Assignor(S) Hereby Confirms the Asignment.
May 1, 2017
From: BLUMBERG, LAURA COOK; DEAVER, DANIEL R.; EYERMAN, DAVID J.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 042380/0706 →
Assignment of Assignor's Interest
Jan 23, 2018
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 044698/0993 →
Assignment of Assignor's Interest
Jan 23, 2018
From: REMENAR, JULIUS F.; BLUMBERG, LAURA COOK; ZEIDAN, TAREK A.
To: ALKERMES, INC.
Reel/Frame 044698/0678 →
Assignment of Assignor's Interest
Jan 23, 2018
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 044704/0184 →
Assignment of Assignor's Interest
Jan 23, 2018
From: BLUMBERG, LAURA COOK; REMENAR, JULIUS F.; ALMARSSON, ORN; ZEIDAN, TAREK A.
To: ALKERMES, INC.
Reel/Frame 044703/0558 →
Assignment of Assignor's Interest
Mar 22, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 045315/0812 →
Corrective Assignment to Correct the Nature of Conveyance from Assignment to Security Agreement Previously Recorded on Reel 045315 Frame 0812. Assignor(S) Hereby Confirms the Security Agreement.
Mar 29, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 045789/0078 →
Assignment of Assignor's Interest
Jun 27, 2018
From: ALKERMES, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 046214/0599 →
Assignment of Assignor's Interest
Nov 9, 2018
From: PERRY, JASON M.; DEAVER, DANIEL R.; HICKEY, MAGALI B.; REMENAR, JULIUS F.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 047461/0093 →
Security Interest
Dec 3, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047661/0244 →
Security Interest
Dec 4, 2018
From: ALKERMES PHARMA IRELAND LIMITED
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 047671/0386 →
Assignment of Assignor's Interest
Dec 23, 2019
From: ZEIDAN, TAREK A.; DUNCAN, SCOTT; HENCKEN, CHRISTOPHER P.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 051354/0700 →
Assignment of Assignor's Interest
Dec 23, 2019
From: ZEIDAN, TAREK A.; DUNCAN, SCOTT; HENCKEN, CHRISTOPHER P.; WYNN, THOMAS ANDREW
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 051354/0678 →
Release of Patent Security Agreements
Dec 24, 2024
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 069771/0701 →
Security Interest
Oct 23, 2025
From: ALKERMES PHARMA IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A. AS ADMINISTRATIVE AGENT
Reel/Frame 073213/0302 →